By providing CT-SCOUT™ to your clinical sites you will both facilitate their contribution to your studies and get a better overview of the site recruitment activities for your studies. You can also further enlarge your patient reach by providing ToTem4me to referral sites, with no need to train them on your studies.
Telemedicine Technologies favors direct contact with patients (with the medical team via ct-scout) and (with an expert clinical trial coordinator via ToTem4me) to involve them wherever they are and empower them to make the decision to participate in a clinical trial.
Through a questionnaire based on a powerful and reliable algorithm, you can pre-select qualified patients for your trial.
A coordinator is made available to the patient following registration on ToTem4me to follow up with the patient before, during and after inclusion in a clinical trial. A notification is sent to the clinical research team once a pest has been detected on CT-SCOUT™.
May 27, 2025
24 June 2025 – 8:00 AM (CET) Join our upcoming webinar in collaboration with PharmaLex to explore current challenges in clinical trials for targeted therapies. We’ll discuss how eClinical solutions can optimize processes—from managing complex data to coordinating stakeholders and enabling real-time decision-making. This interactive session is designed for industry professionals at the intersection of […]
May 27, 2025
28 May 2025 – 04:00 PM to 05:00 PM CET (Webinar) Yoanni Th. Matsakis, President of Telemedicine Technologies, attends the first xShare webinar on the EHDS Adoption Kit for citizens. The event introduces the European Health Data Space (EHDS) and the European Electronic Health Record Exchange Format (EEHRxF). It explores data-driven healthcare through “The Health […]
May 27, 2025
Med City News Artificial intelligence is being incorporated into more places in healthcare, for uses such as guiding clinical trial enrollment as well as helping physicians get up to speed on a patient’s history. A panel discussed these applications and more during MedCity News’s INVEST conference in Chicago. In the life sciences community, there’s a […]